Cargando…
RB1 loss triggers dependence on ESRRG in retinoblastoma
Retinoblastoma (Rb) is a deadly childhood eye cancer that is classically initiated by inactivation of the RB1 tumor suppressor. Clinical management continues to rely on nonspecific chemotherapeutic agents that are associated with treatment resistance and toxicity. Here, we analyzed 103 whole exomes,...
Autores principales: | Field, Matthew G., Kuznetsoff, Jeffim N., Zhang, Michelle G., Dollar, James J., Durante, Michael A., Sayegh, Yoseph, Decatur, Christina L., Kurtenbach, Stefan, Pelaez, Daniel, Harbour, J. William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390996/ https://www.ncbi.nlm.nih.gov/pubmed/35984874 http://dx.doi.org/10.1126/sciadv.abm8466 |
Ejemplares similares
-
Early Mechanisms of Chemoresistance in Retinoblastoma
por: Zhang, Michelle G., et al.
Publicado: (2022) -
PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023) -
BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas
por: Kaler, Christopher J., et al.
Publicado: (2022) -
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer
por: Miao, Chenkui, et al.
Publicado: (2022) -
PieParty: visualizing cells from scRNA-seq data as pie charts
por: Kurtenbach, Stefan, et al.
Publicado: (2021)